Atea Pharmaceuticals Past Performance
How has Atea Pharmaceuticals performed over the past 5 years?
Past Performance Score
4/6Past Performance Score 4/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
74.9%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AVIR has high quality earnings.
Growing Profit Margin: AVIR's current net profit margins (18.6%) are higher than last year (11.9%).
Past Earnings Growth Analysis
Earnings Trend: AVIR's earnings have grown significantly by 74.9% per year over the past 5 years.
Accelerating Growth: AVIR's earnings growth over the past year (44.3%) is below its 5-year average (74.9% per year).
Earnings vs Industry: AVIR earnings growth over the past year (44.3%) exceeded the Pharmaceuticals industry 7%.
Return on Equity
High ROE: AVIR's Return on Equity (5.4%) is considered low.